Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Lakefront Biotherapeutics trades below book with a market cap of roughly $1.78B while carrying a deeper pipeline and recent FDA orphan designation for gamgertamig. Technicals show near-term weakness, but the combination of shareholder accumulation and regulatory catalysts supports a mid-term long trade with tight risk controls.
Lifeward Ltd. announced publication of a landmark peer-reviewed study demonstrating that users of its ReWalk personal exoskeleton with chronic spinal cord injury showed significant improvements in performing daily activities, greater satisfaction, and reduced pain compared to wheelchair use. The study involved 12 patients and highlighted functional…
Sunrise Realty Trust, a Nasdaq-listed commercial real estate lender, announced a quarterly dividend of $0.30 per share for Q3 2026, consistent with the previous quarter. The dividend is payable on October 15, 2026, to shareholders of record on September 30, 2026.
Advanced Flower Capital Inc. announced a quarterly dividend of $0.05 per share for Q3 2026, consistent with the previous quarter's dividend. This payment reflects the company’s ongoing commitment to delivering steady returns to shareholders.
SCYNEXIS, a clinical-stage biotech company focused on severe rare diseases, appointed Dr. Todd Minga as Senior Vice President of Research & Development to lead advancement of their pipeline, including SCY-770 for polycystic kidney disease and antifungal programs. Dr. Minga brings extensive clinical and strategic experience in kidney disease and dru…
Vera Bradley, Inc. announced financial results for its second quarter of fiscal 2027, reporting 1.1% growth in consolidated net revenues to $71.6 million, driven by an 8% increase in its Direct segment. The company achieved positive operating income and net income from continuing operations, reversing prior losses. Inventory reduced significantly b…
Cass Information Systems, Inc. (Nasdaq: CASS) was named a 2026-27 Hot Company by PARCEL, highlighting its leadership in parcel spend management. The company offers comprehensive solutions including invoice auditing, carrier performance analysis, and payment management that help large shippers optimize costs and improve financial accuracy amidst gro…
Mixed Martial Arts Group Limited (NYSE American: MMA) announced that its BJJLink software platform has been deployed at the first UFC GYM standalone jiu-jitsu studio in New York, with a second location in Florida opening soon. The platform supports memberships, billing, payments, scheduling, and student progression, enabling recurring software and …
Algorhythm Holdings, Inc., a NASDAQ-listed AI technology company specializing in supply-chain optimization through its SemiCab platform, has announced the departure of CEO Gary Atkinson following a strategic acquisition and corporate repositioning. The leadership transition accompanies the acquisition of an EBITDA-positive energy sector business an…
Genius Group Limited announced a new analyst report from Diamond Equity Research highlighting the company's 156% year-on-year revenue growth in H1 2026, profitability achieved post-2025 restructuring, and a strategic $100 million AI Treasury Plan focused on frontier AI investments. The report values Genius Group at $1.54 per share, emphasizing net …
Biodexa Pharmaceuticals PLC announced a warrant exercise transaction with an accredited investor, resulting in gross proceeds of approximately $2.3 million. The transaction involves the exercise of existing warrants at $1.05 per ADS and issuance of new warrants for future capital. Proceeds will support continued clinical development of their drug c…
LB Pharmaceuticals has appointed Dr. Susan G. Kozauer as Chief Medical Officer. Dr. Kozauer brings over 20 years of neuropsychiatric drug development expertise, including leading clinical development of CAPLYTA for schizophrenia and mood disorders. Her appointment comes at a critical time as LB Pharmaceuticals prepares for topline results from its …
Teads announced the appointment of Alex Underwood as Managing Director of North America and Alena Morris as Senior Vice President, Client Solutions & Strategic Products. These strategic hires aim to accelerate growth in North America and enhance commercial solutions globally, leveraging their extensive experience in the advertising and media techno…
Nasdaq Verafin and Stablecore announced a strategic partnership integrating digital asset transaction data with traditional banking data to provide financial institutions a comprehensive platform for detecting financial crime across both fiat and digital assets. The collaboration aims to improve visibility into transactional flows, enhancing compli…
Winnebago Industries is presenting over 150 new RV models across its three premium brands—Winnebago, Grand Design RV, and Newmar—at the 57th annual America's Largest RV Show. Highlights include the debut of the Winnebago ARKA adventure motorhome with advanced off-grid capabilities, Grand Design's entry-level Transcend Lite and first gas-powered mot…
HP Inc. announced the HP ZBook Ultra G3a, a 16-inch thin-and-light mobile workstation designed for local AI workloads, supporting large language models up to 300 billion parameters, with up to 192GB unified memory and 160GB VRAM. The workstation integrates Perplexity Computer and supports Autodesk Revit to enable seamless AI workflows for professio…
ONEOK, Inc. announced the early results of its cash tender offers to repurchase up to $2 billion aggregate principal amount of debt securities issued by its subsidiary ONEOK, L.L.C. These offers prioritize tendered notes by specified acceptance levels and aim to manage the company's capital structure. The company expects no tenders will be accepted…
Cogent Biosciences announced the FDA acceptance of its New Drug Application for bezuclastinib in treating Advanced Systemic Mastocytosis (AdvSM), supported by positive pivotal trial data demonstrating significant clinical responses and disease modification. The FDA assigned a PDUFA date of June 29, 2027, with no advisory committee planned. Addition…
Kaltura has been named the 'Company to Beat' by Gartner in the AI race for video platform services. The report highlights Kaltura's comprehensive AI integration across video creation, management, and delivery, emphasizing its innovative Agentic Avatars and Genies which enable interactive, context-aware video experiences. This recognition validates …
Quantum BioPharma announced its participation in the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto where it will discuss recent milestones, including the FDA's approval for its Investigational New Drug application to begin Phase 2 clinical trials of Lucid-MS, a novel treatment targeting progressive multiple sclerosis. This event positions …
Baird Medical Investment Holdings Limited, a Nasdaq-listed medical device company specializing in minimally invasive ablation treatments, announced it will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover the company's FDA-cleared microwave ablation system for soft tissue ablation, commercial expa…
Allarity Therapeutics, a clinical-stage pharmaceutical company listed on NASDAQ, announced that the Japan Patent Office granted a key patent covering its stenoparib-specific Drug Response Predictor (DRP®) companion diagnostic. This patent protection in Japan extends into 2039, complementing existing patents in the U.S., Europe, and Australia, there…
Upexi, Inc., a Nasdaq-listed digital asset treasury company focused on Solana cryptocurrency and consumer brands, announced its fiscal year 2026 earnings call scheduled for September 17, 2026. The company aims to report financial results and provide insights into its operations, which include holding a significant amount of Solana and managing cons…
FTC Solar announced it has received approval to begin production for the 82 MW Sybella Creek Solar Farm in Queensland, Australia, with deliveries planned from late 2026 to early 2027. Utilizing FTC Solar's Voyager 2P tracker technology, this hybrid solar and battery storage project aims to boost energy security in Mount Isa and strengthens the comp…
Legend Biotech announces the appointment of Ingrid Zhang as CEO, effective September 15, 2026. Zhang brings extensive global biopharmaceutical leadership experience, including roles at Novartis and AstraZeneca. The company aims to leverage her expertise to advance its cell therapy pipeline, expand commercial reach, and execute long-term growth stra…
